Christopher M. Yea
2023
In 2023, Christopher M. Yea earned a total compensation of $1.7M as Chief Development Officer at Carbylan Therapeutics, a 38% decrease compared to previous year.
Compensation breakdown
| Bonus | $133,770 |
|---|---|
| Option Awards | $138,909 |
| Salary | $477,750 |
| Stock Awards | $871,479 |
| Other | $28,709 |
| Total | $1,650,617 |
Yea received $871.5K in stock awards, accounting for 53% of the total pay in 2023.
Yea also received $133.8K in bonus, $138.9K in option awards, $477.8K in salary and $28.7K in other compensation.
Rankings
In 2023, Christopher M. Yea's compensation ranked 694th out of 3,006 executives tracked by ExecPay. In other words, Yea earned more than 76.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 694 out of 3,006 | 77th |
Division Manufacturing | 393 out of 1,650 | 76th |
Major group Chemicals And Allied Products | 268 out of 918 | 71st |
Industry group Drugs | 263 out of 881 | 70th |
Industry Pharmaceutical Preparations | 169 out of 637 | 74th |
Source: SEC filing on August 14, 2023.
Yea's colleagues
We found two more compensation records of executives who worked with Christopher M. Yea at Carbylan Therapeutics in 2023.